Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026
Go back to Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 135.61 -4.72 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $140.33 | 52 Week High | $0.52 | |||
| Open | $140.29 | 52 Week Low | $0.08 | |||
| Day High | $143.94 | P/E | N/A | |||
| Day Low | $135.52 | EPS | $-3.80 | |||
| Volume | 8,645,177 | |||||
